Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Belinda Jackson & Peter De Cruz. (2018) Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis. Expert Review of Gastroenterology & Hepatology 12:11, pages 1079-1100.
Read now
Read now
Kai Dong, Hefeng Zhang, Yan Yan, Jinyao Sun, Yalin Dong, Ke Wang, Lu Zhang, Xianpeng Shi & Jianfeng Xing. (2017) Improvement of side-effects and treatment on the experimental colitis in mice of a resin microcapsule-loading hydrocortisone sodium succinate. Drug Development and Industrial Pharmacy 43:3, pages 448-457.
Read now
Read now
Mette Julsgaard, Mette Nørgaard, Christian Lodberg Hvas, Anne Grosen, Sara Hasseriis & Lisbet Ambrosius Christensen. (2014) Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn’s disease. Scandinavian Journal of Gastroenterology 49:8, pages 958-966.
Read now
Read now
Å. Nilsson. (2006) Optimizing management of distal ulcerative colitis. Scandinavian Journal of Gastroenterology 41:5, pages 511-523.
Read now
Read now
Articles from other publishers (60)
Atheer Awad, Alvaro Goyanes, Mine Orlu, Simon Gaisford & Abdul W. Basit. (2023) 3D printed infliximab suppositories for rectal biologic delivery. International Journal of Pharmaceutics: X 5, pages 100176.
Crossref
Crossref
Achuthan Aruljothy, Siddharth Singh, Neeraj Narula, Gordon W. Moran, Sudheer K. Vuyyuru, Malcolm Hogan, Alexa Zayadi, John K. MacDonald, Benedicte Caron, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma & Vipul Jairath. (2023) Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary Pharmacology & Therapeutics.
Crossref
Crossref
Kazuhiko Uchiyama, Tomohisa Takagi, Katsura Mizushima, Kohei Asaeda, Mariko Kubota-Kajiwara, Takeshi Sugaya, Saori Kashiwagi, Yuki Minagawa, Yuma Hotta, Makoto Tanaka, Ken Inoue, Kazuhiro Katada, Kazuhiro Kamada, Takeshi Ishikawa, Hiroaki Yasuda, Hideyuki Konishi, Mitsuo Kishimoto, Yuji Naito & Yoshito Itoh. (2023) Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis. Inflammatory Intestinal Diseases 8:2, pages 84-90.
Crossref
Crossref
Bénédicte Caron, William J Sandborn, Remo Panaccione, Stefan Schreiber, Ailsa Hart, Virginia Solitano, Silvio Danese & Laurent Peyrin-Biroulet. (2022) Efficacy of Pharmacological Agents for Ulcerative Proctitis: A Systematic Literature Review. Journal of Crohn's and Colitis 16:6, pages 922-930.
Crossref
Crossref
Wolfgang Kruis, Britta Siegmund, Konrad Lesniakowski, Vladimir Simanenkov, Ludmila Khimion, Marcin Sobon, Glebs Delmans, Svetlana V Maksyashina, Oleg A Sablin, Juris Pokrotnieks, Yuriy Mostovoy, Olena Datsenko, Sayar Abdulkhakov, Andriy Dorofeyev, Olena Levchenko, Olga Alexeeva, Pavel Andreev, Ivan P Kolesnik, Emese Mihaly, Orest Abrahamovych, Malgorzata Baluta, Nataliia Kharchenko, Neshta Viacheslav, Yury Uspenskiy, Michael Vieth, Ralf Mohrbacher, Ralph Mueller & Roland Greinwald. (2022) Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial. Journal of Crohn's and Colitis.
Crossref
Crossref
Tim Raine, Stefanos Bonovas, Johan Burisch, Torsten Kucharzik, Michel Adamina, Vito Annese, Oliver Bachmann, Dominik Bettenworth, Maria Chaparro, Wladyslawa Czuber-Dochan, Piotr Eder, Pierre Ellul, Catarina Fidalgo, Gionata Fiorino, Paolo Gionchetti, Javier P Gisbert, Hannah Gordon, Charlotte Hedin, Stefan Holubar, Marietta Iacucci, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Peter L Lakatos, Theodore Lytras, Ivan Lyutakov, Nurulamin Noor, Gianluca Pellino, Daniele Piovani, Edoardo Savarino, Francesco Selvaggi, Bram Verstockt, Antonino Spinelli, Yves Panis & Glen Doherty. (2022) ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. Journal of Crohn's and Colitis 16:1, pages 2-17.
Crossref
Crossref
Bénédicte Caron, William J Sandborn, Stefan Schreiber, Remo Panaccione, Silvio Danese & Laurent Peyrin-Biroulet. (2021) Drug development for ulcerative proctitis: current concepts. Gut 70:7, pages 1203-1209.
Crossref
Crossref
Jonathan Blackwell, Christian Selinger, Tim Raine, Gareth Parkes, Melissa A Smith & Richard Pollok. (2021) Steroid use and misuse: a key performance indicator in the management of IBD. Frontline Gastroenterology 12:3, pages 207-213.
Crossref
Crossref
Maryam Alkhatry, Ahmad Al-Rifai, Vito Annese, Filippos Georgopoulos, Ahmad N Jazzar, Ahmed M Khassouan, Zaher Koutoubi, Rahul Nathwani, Mazen S Taha & Jimmy K Limdi. (2020) First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World Journal of Gastroenterology 26:43, pages 6710-6769.
Crossref
Crossref
Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kirandeep Kaur, Rajeev Khosla, Ajay Kumar, Ramit Mahajan, S. P. Misra, Kiran Peddi, Shivaram Prasad Singh & Arshdeep Singh. (2020) Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease. Intestinal Research 18:4, pages 355-378.
Crossref
Crossref
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen & A Barney Hawthorne. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:Suppl 3, pages s1-s106.
Crossref
Crossref
Cynthia W. Ko, Siddharth Singh, Joseph D. Feuerstein, Corinna Falck-Ytter, Yngve Falck-Ytter, Raymond K. Cross, Seth Crockett, Yngve Falck-Ytter, Joseph Feuerstein, Steven Flamm, John Inadomi, Cynthia Ko, Thiruvengadam Muniraj, Robert O’Shea, John Pandolfino, Amit Patel, Ravi Sharaf, Shazia Siddique, Grace Su, Kenneth Wang & Adam Weizman. (2019) AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 156:3, pages 748-764.
Crossref
Crossref
Siddharth Singh, Joseph D. Feuerstein, David G. Binion & William J. Tremaine. (2019) AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 156:3, pages 769-808.e29.
Crossref
Crossref
Caroline Baehler, Beat Brüngger, Eva Blozik, Stephan R. Vavricka & Alain M. Schoepfer. (2019) Real-World Data on Topical Therapies and Annual Health Resource Utilization in Hospitalized Swiss Patients with Ulcerative Colitis. Inflammatory Intestinal Diseases 4:4, pages 144-153.
Crossref
Crossref
Shingo Kato, Akira Ishibashi, Kazuhito Kani & Koji Yakabi. (2018) Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository. Digestion 97:1, pages 59-63.
Crossref
Crossref
Xiaojing Zhao, Changcheng Zhou, Jingjing Ma, Yunjuan Zhu, Min Sun, Peixue Wang, Yi Zhang, Haiqin Ma & Hongjie Zhang. (2017) Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis. Scientific Reports 7:1.
Crossref
Crossref
Jian Zeng, Lin Lv & Zhe-Chuan Mei. (2017) Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology 32:3, pages 558-566.
Crossref
Crossref
Chang Hwan ChoiWon MoonYou Sun KimEun Soo KimBo-In LeeYunho JungYong Sik YoonHeeyoung LeeDong Il ParkDong Soo Han. (2017) Second Korean guidelines for the management of ulcerative colitis. Intestinal Research 15:1, pages 7.
Crossref
Crossref
Chang Hwan ChoiWon MoonYou Sun KimEun Soo KimBo-In LeeYunho JungYong Sik YoonHeeyoung LeeDong Il ParkDong Soo Han. (2017) Second Korean Guideline for the Management of Ulcerative Colitis. The Korean Journal of Gastroenterology 69:1, pages 1.
Crossref
Crossref
Brian Bressler, John K. Marshall, Charles N. Bernstein, Alain Bitton, Jennifer Jones, Grigorios I. Leontiadis, Remo Panaccione, A. Hillary Steinhart, Francis Tse, Brian Feagan, Waqqas Afif, Edmond-Jean Bernard, Mark Borgaonkar, Shane Devlin, Richard Fedorak, Geoffrey C. Nguyen, Robert Penner, Laurent Peyrin-Biroulet, Walter Reinisch, Cynthia H. Seow, Richmond Sy, Laura Targownik, Peter Thomson, Gert Van Assche & Chadwick Williams. (2015) Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus. Gastroenterology 148:5, pages 1035-1058.e3.
Crossref
Crossref
Gudula JAM Boon. (2015) Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?. World Journal of Gastroenterology 21:40, pages 11469.
Crossref
Crossref
Mitchell R. K. L. Lie, Shannon L. Kanis, Bettina E. Hansen & C. Janneke van der Woude. (2014) Drug Therapies for Ulcerative Proctitis. Inflammatory Bowel Diseases 20:11, pages 2157-2178.
Crossref
Crossref
Gionata Fiorino, Daniela Gilardi, Patrizia Naccarato, Orsola R. Sociale & Silvio Danese. (2014) Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis. Digestive and Liver Disease 46:4, pages 330-334.
Crossref
Crossref
Mahmoud H. Mosli, Brian G. Feagan, William J. Sandborn, Geert DʼHaens, Cynthia Behling, Keith Kaplan, David K. Driman, Lisa M. Shackelton, Kenneth A. Baker, John K. MacDonald, Margaret K. Vandervoort, Karel Geboes & Barrett G. Levesque. (2014) Histologic Evaluation of Ulcerative Colitis. Inflammatory Bowel Diseases 20:3, pages 564-575.
Crossref
Crossref
Sushila Dalal & Russell D. Cohen. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
101
110
.
Sunanda V. Kane. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
327
333
.
Seymour Katz. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
121
133
.
Ken Fukunaga, Yoshio Ohda, Nobuyuki Hida, Masaki Iimuro, Yoko Yokoyama, Koji Kamikozuru, Kazuko Nagase, Shiro Nakamura, Hiroto Miwa & Takayuki Matsumoto. (2012) Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis. Journal of Gastroenterology and Hepatology 27:12, pages 1808-1815.
Crossref
Crossref
Tessa E.H. Römkens, Milou T. Kampschreur, Joost P.H. Drenth, Martijn G.H. van Oijen & Dirk J. de Jong. (2012) High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials. Inflammatory Bowel Diseases 18:11, pages 2190-2198.
Crossref
Crossref
Nicolette A. Louissaint, Sridhar Nimmagadda, Edward J. Fuchs, Rahul P. Bakshi, Ying-Jun Cao, Linda A. Lee, Jeff Goldsmith, Brian S. Caffo, Yong Du, Karen E. King, Frederick A. Menendez, Michael S. Torbenson & Craig W. Hendrix. (2012) Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Colon After Simulated Receptive Anal Intercourse in Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes 59:1, pages 10-17.
Crossref
Crossref
Mette Julsgaard, Mette Nørgaard, Christian Lodberg Hvas, Daniel Buck & Lisbet Ambrosius Christensen. (2011) Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflammatory Bowel Diseases 17:7, pages 1573-1580.
Crossref
Crossref
James D. Lewis. (2011) The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease. Gastroenterology 140:6, pages 1817-1826.e2.
Crossref
Crossref
Wojciech Blonski, David Kotlyar & Gary R. Lichtenstein. 2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease
73
92
.
M. J. Nielsen, M. Nørgaard, P. Holland‐Fisher & L. A. Christensen. (2010) Self‐reported antenatal adherence to medical treatment among pregnant women with Crohn’s disease. Alimentary Pharmacology & Therapeutics 32:1, pages 49-58.
Crossref
Crossref
John K Marshall, Marroon Thabane, A Hillary Steinhart, Jamie R Newman, Anju Anand & E Jan Irvine. (2010) Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jay Bhatt, Samir Patil, Anand Joshi, Philip Abraham & Devendra Desai. (2009) Self-reported treatment adherence in inflammatory bowel disease in Indian patients. Indian Journal of Gastroenterology 28:4, pages 143-146.
Crossref
Crossref
G. J. Mantzaris. 2008. IBD 2007 — Achievements in Research and Clinical Practice. IBD 2007 — Achievements in Research and Clinical Practice
189
207
.
Maria M Oliva-Hemker, Vivian Abadom, Carmen Cuffari & Richard E Thompson. (2007) Nonadherence With Thiopurine Immunomodulator and Mesalamine Medications in Children with Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 44:2, pages 180-184.
Crossref
Crossref
Isabel Bernal, Eugeni Domènech, Esther Garcia-Planella, Laura Marín, Míriam Mañosa, Mercè Navarro, Eduard Cabré & Miquel A. Gassull. (2006) Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 51:12, pages 2165-2169.
Crossref
Crossref
A. LÓPEZ‐SANROMÁN & F. BERMEJO. (2006) Review article: how to control and improve adherence to therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 24:s3, pages 45-49.
Crossref
Crossref
Miguel Regueiro, Edward V. Loftus, Hillary A. Steinhart & Russell D. Cohen. (2006) Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials. Inflammatory Bowel Diseases 12:10, pages 979-994.
Crossref
Crossref
Steven Masson, David Nylander & John C Mansfield. (2005) How Important is Onset of Action in Ulcerative Colitis Therapy?. Drugs 65:15, pages 2069-2083.
Crossref
Crossref
Altamash I. Qureshi & Russell D. Cohen. (2005) Mesalamine delivery systems: do they really make much difference?. Advanced Drug Delivery Reviews 57:2, pages 281-302.
Crossref
Crossref
William J. Sandborn. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
605
629
.
Miguel D Regueiro. (2004) Diagnosis and Treatment of Ulcerative Proctitis. Journal of Clinical Gastroenterology 38:9, pages 733-740.
Crossref
Crossref
Philippe Seksik, Jean-François Contou, Philippe Ducrotté, Jean-Luc Faucheron & Vincent De Parades. (2004) Traitement de la rectocolite ulcéro-hémorragique dans sa forme distale. Gastroentérologie Clinique et Biologique 28:10, pages 964-973.
Crossref
Crossref
Sonia Friedman. (2004) General principles of medical therapy of inflammatory bowel disease. Gastroenterology Clinics of North America 33:2, pages 191-208.
Crossref
Crossref
Maida J Sewitch, Karen Leffondré & Patricia L Dobkin. (2004) Clustering patients according to health perceptions. Journal of Psychosomatic Research 56:3, pages 323-332.
Crossref
Crossref
Maida J Sewitch, Michal Abrahamowicz, Alan Barkun, Alain Bitton, Gary E Wild, Albert Cohen & Patricia L Dobkin. (2003) Patient Nonadherence To Medication in Inflammatory Bowel Disease. American Journal of Gastroenterology 98:7, pages 1535-1544.
Crossref
Crossref
G. Aumais, M. Lefebvre, C. Tremblay, A. Bitton, F. Martin, A. Giard, M. Madi & J. Spénard. (2003) Rectal tissue, plasma and urine concentrations of mesalazine after single and multiple administrations of 500 mg suppositories to healthy volunteers and ulcerative proctitis patients. Alimentary Pharmacology & Therapeutics 17:1, pages 93-97.
Crossref
Crossref
William J. Sandborn. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
605
629
.
Subhas Banerjee & Mark A Peppercorn. (2002) Inflammatory bowel disease. Gastroenterology Clinics of North America 31:1, pages 185-202.
Crossref
Crossref
Sauid Ishaq & Jonathan R. Green. (2001) Tolerability of Aminosalicylates in Inflammatory Bowel Disease. BioDrugs 15:5, pages 339-349.
Crossref
Crossref
Martine de Vos. (2000) Clinical Pharmacokinetics of Slow Release Mesalazine. Clinical Pharmacokinetics 39:2, pages 85-97.
Crossref
Crossref
John K Marshall & Jan E Irvine. (2000) Putting Rectal 5-Aminosalicylic Acid in Its Place: The Role in Distal Ulcerative Colitis. American Journal of Gastroenterology 95:7, pages 1628-1636.
Crossref
Crossref
Russell D Cohen, Douglas M Woseth, Ronald A Thisted & Stephen B Hanauer. (2000) A Meta-Analysis and Overview of The Literature on Treatment Options for Left-Sided Ulcerative Colitis and Ulcerative Proctitis. American Journal of Gastroenterology 95:5, pages 1263-1276.
Crossref
Crossref
Philippe Marteau & Christian Florent. (2000) Comparative, open, randomized trial of the efficacy and tolerance of slow- release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis. The American Journal of Gastroenterology 95:1, pages 166-170.
Crossref
Crossref
Pierre Michetti & Mark A. Peppercorn. (1999) MEDICAL THERAPY OF SPECIFIC CLINICAL PRESENTATIONS. Gastroenterology Clinics of North America 28:2, pages 353-370.
Crossref
Crossref
Sunanda Kane. (1999) Patient Compliance and Outcomes. Inflammatory Bowel Diseases 5:2, pages 134-137.
Crossref
Crossref
Teruki Teshima, Gerald E. Hanks, Alexandra L. Hanlon, Ruth S. Peter & Timothy E. Schultheiss. (1997) Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity. International Journal of Radiation Oncology*Biology*Physics 39:1, pages 77-83.
Crossref
Crossref